Pacer Advisors, Inc. Haemonetics Corp Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 7,658 shares of HAE stock, worth $596,328. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,658

Previous 7,562 1.27%

Holding current value

$596,328

Previous $645,000 1.86%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$81.24 - $97.37 $7,799 - $9,347	96 Added 1.27%	7,658 $633,000
Q1 2024 May 10, 2024	SELL	$71.24 - $85.35 $109,424 - $131,097	-1,536 Reduced 16.88%	7,562 $645,000
Q4 2023 Jan 16, 2024	BUY	$80.59 - $92.61 $288,431 - $331,451	3,579 Added 64.85%	9,098 $777,000
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $419,404 - $474,929	-5,080 Reduced 47.93%	5,519 $494,000
Q2 2023 Jul 12, 2023	BUY	$80.84 - $89.45 $856,823 - $948,080	10,599 New	10,599 $902,000
Q4 2022 Feb 06, 2023	BUY	$73.85 - $86.14 $559,856 - $653,027	7,581 Added 358.61%	9,695 $762,000
Q3 2022 Oct 18, 2022	BUY	$63.3 - $78.66 $133,816 - $166,287	2,114 New	2,114 $156,000
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $217,773 - $292,073	-4,420 Closed	0 $0
Q1 2022 Apr 05, 2022	SELL	$43.77 - $63.22 $38,473 - $55,570	-879 Reduced 16.59%	4,420 $279,000
Q4 2021 Feb 03, 2022	BUY	$49.55 - $74.59 $3,121 - $4,699	63 Added 1.2%	5,299 $281,000
Q3 2021 Oct 15, 2021	SELL	$57.6 - $70.59 $113,817 - $139,485	-1,976 Reduced 27.4%	5,236 $370,000
Q2 2021 Jul 21, 2021	BUY	$51.81 - $118.56 $92,584 - $211,866	1,787 Added 32.94%	7,212 $481,000
Q1 2021 Apr 05, 2021	SELL	$111.01 - $139.48 $22,646 - $28,453	-204 Reduced 3.62%	5,425 $602,000
Q4 2020 Jan 20, 2021	SELL	$88.75 - $119.95 $581,578 - $786,032	-6,553 Reduced 53.79%	5,629 $668,000
Q3 2020 Oct 19, 2020	BUY	$75.65 - $93.58 $921,568 - $1.14 Million	12,182 New	12,182 $1.06 Million
Q1 2020 Apr 23, 2020	SELL	$74.34 - $121.82 $1.28 Million - $2.1 Million	-17,218 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$114.37 - $129.46 $184,478 - $208,818	-1,613 Reduced 8.57%	17,218 $1.98 Million
Q3 2019 Oct 10, 2019	SELL	$117.16 - $138.52 $171,287 - $202,516	-1,462 Reduced 7.2%	18,831 $2.38 Million
Q2 2019 Aug 12, 2019	BUY	$81.74 - $120.34 $1.66 Million - $2.44 Million	20,293 New	20,293 $2.44 Million
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $1.68 Million - $2.16 Million	-18,532 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $181,899 - $231,680	2,022 Added 12.25%	18,532 $2.12 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $1.18 Million - $1.58 Million	16,510 New	16,510 $1.48 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Haemonetics Corp Transaction History